Market cap
₹29 Cr
Revenue (TTM)
₹24 Cr
P/E Ratio
--
P/B Ratio
-15.8
Div. Yield
0 %
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
29 | 216 | 135 | 33 | 26 |
Revenue (₹ Cr) |
24 | 62 | 24 | 17 | 0 |
Net Profit (₹ Cr) |
-1.91 | 0.47 | -3.45 | 2.19 | -3.90 |
Net Margin (%) |
-7.87 | 0.75 | -14.04 | 12.01 | -7,806.00 |
RoE (%) |
-- | 0.72 | -29.63 | 6.02 | -33.78 |
Price to Earnings |
-- | 455.94 | -- | 15.26 | -- |
Price-To-Book |
-15.81 | 3.52 | 12.22 | 0.85 | 2.30 |
Income Statement (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Operating Revenue
|
24.33 | 61.94 | 24.07 | 16.90 | 0.02 |
|
Total Income
|
24.33 | 63.12 | 24.54 | 18.20 | 0.05 |
|
Total Expenditure
|
24.14 | 55.31 | 25.95 | 15.04 | 3.95 |
|
EBITDA
|
0.19 | 6.63 | -1.87 | 1.86 | -3.93 |
|
Depreciation
|
0.50 | 5.42 | 1.64 | 0.55 | 0.00 |
|
EBIT
|
-0.31 | 1.21 | -3.52 | 1.30 | -3.94 |
|
Interest
|
1.52 | 1.72 | 0.40 | 0.06 | 0.00 |
|
Other Income
|
0.00 | 1.18 | 0.47 | 1.30 | 0.03 |
|
Exceptional Items
|
0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-1.84 | 0.71 | -3.45 | 2.55 | -3.90 |
|
Provision for Tax
|
0.08 | 0.24 | 0.00 | 0.37 | 0.00 |
|
Profit after Tax
|
-1.91 | 0.47 | -3.45 | 2.19 | -3.90 |
Liabilities (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-1.65 | 61.21 | 11.03 | 39.09 | 11.28 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
11.90 | 22.13 | 4.51 | 0.00 | 0.09 |
|
Current Liabilities
|
17.36 | 17.24 | 3.68 | 2.99 | 2.55 |
|
Total Liabilities
|
22.17 | 69.57 | 17.46 | 41.62 | 15.57 |
Assets (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
6.47 | 61.32 | 9.57 | 39.45 | 11.91 |
|
Current Assets
|
18.86 | 11.58 | 5.25 | 2.51 | 2.02 |
|
Total Assets
|
22.17 | 69.57 | 17.46 | 41.62 | 15.57 |
|
Total Debt*
|
10.52 | 0.61 | 1.21 | 1.78 | 2.43 |
|
Net Current Assets
|
1.50 | -5.67 | 1.57 | -0.49 | -0.53 |
|
Contingent Liabilities
|
0.03 | 0.82 | 1.12 | 0.09 | -- |
Cashflow (₹ Cr)
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1.47 | 2.70 | 1.83 | 1.81 | -0.23 |
|
Cash Flow from Investing Activities
|
-0.52 | -3.99 | 0.12 | -1.23 | -- |
|
Cash from Financing Activities
|
-0.24 | -1.60 | -0.99 | -0.62 | 0.22 |
|
Net Cash Inflow / Outflow
|
0.71 | -2.89 | 0.95 | -0.03 | 0.00 |
Ratios
Profitability Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.58 | 3.10 | 19.27 | 23.83 | -1.79 |
|
ROE (%)
|
-12.79 | 0.72 | -29.63 | 6.02 | -33.78 |
|
ROA (%)
|
-7.44 | 0.55 | -17.50 | 5.14 | -24.37 |
|
EBIT Margin (%)
|
-1.29 | 1.95 | -14.61 | 7.72 | -21,861.11 |
|
Net Margin (%)
|
-7.87 | 0.75 | -14.04 | 12.01 | -7,806.00 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | -0.54 |
Growth Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-17.03 | 23.11 | -1.86 | 4.22 | -- |
|
EBIT Growth (%)
|
-7,750.00 | 150.52 | -206.09 | 31.72 | -4.35 |
|
Net Profit Growth (%)
|
-92.17 | -30.13 | -201.29 | -55.37 | -3.83 |
|
EPS Growth (%)
|
-92.17 | -34.69 | -201.29 | -55.37 | -8.58 |
|
Book Value Growth (%)
|
-19.64 | 1.00 | 19.94 | 6.59 | -2.32 |
Valuation Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-15.09 | 491.88 | -39.12 | 15.26 | -6.69 |
|
Price / Book Value
|
-15.81 | 3.52 | 12.22 | 0.85 | 2.30 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 3.52 | 0.00 |
|
EV/EBITDA
|
200.98 | 33.78 | -71.78 | 18.09 | -6.63 |
|
Market Cap (₹ Cr)
|
20.42 | 145.37 | 87.73 | 54.63 | -- |
Solvency Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-6.49 | 0.20 | 0.13 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.31 | -- | -- | 0.05 | 0.20 |
|
Current Ratio
|
1.09 | 0.67 | 1.43 | 0.84 | 0.79 |
|
Quick Ratio
|
1.05 | 0.43 | 1.19 | 0.56 | 0.79 |
|
Interest Coverage
|
-0.21 | 1.41 | -7.55 | 46.55 | -182.25 |
Operating Efficiency Ratios
| Soni Medicare | Lotus Eye Hosp | Aspira Pathlab | NG | Samsrita Labs | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
58.59 | 2.55 | 11.03 | 1.07 | 55.56 |
|
Asset Turnover
|
0.95 | 0.72 | 1.22 | 0.40 | 0.00 |
|
Receivable days
|
96.98 | 9.50 | 38.11 | 6.31 | -- |
|
Inventory Days
|
8.69 | 25.93 | 7.95 | 15.24 | -- |
|
Payable days
|
251.51 | 80.52 | 72.32 | 0.00 | -- |
|
Cash Conversion Cycle
|
-145.84 | -45.09 | -26.26 | 21.54 | -- |